Stay updated on PCSK9 Inhibition After Heart Transplantation Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition After Heart Transplantation Clinical Trial page.

Latest updates to the PCSK9 Inhibition After Heart Transplantation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study record history shows a new revision entry: Revision: v3.6.4 was added, replacing the previous Revision: v3.6.3. This reflects an update to the record’s version in the history, indicating a newer iteration of the study record.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRecord History now shows new entries like Returned: 2026-07-09 and Quality Control Review Has Not Concluded, along with additional sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Study Status. This reflects an expanded and more organized presentation of study data in the version history.SummaryDifference1%

- Check33 days agoChange DetectedThe study record history adds a new revision entry (v3.6.3) replacing the previous v3.6.2, indicating an updated version of the record.SummaryDifference0.1%

- Check40 days agoChange DetectedThe record history adds a newer revision entry (v3.6.2) and removes the earlier revision (v3.6.0) from the current list of versions.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history now shows Results Submitted, replacing the previous No Results Posted status, indicating that the study's results have been completed and submitted to ClinicalTrials.gov.SummaryDifference0.1%

- Check54 days agoChange DetectedThe history includes a new note that the study is no longer looking for participants, indicating enrollment has ended. It also adds a new release version (v3.6.0) and removes the previous version note (v3.5.5).SummaryDifference0.4%

Stay in the know with updates to PCSK9 Inhibition After Heart Transplantation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition After Heart Transplantation Clinical Trial page.